M4MM Rescheduling Cannabis Booklet 2024

LONGFORM GENERIC LETTER FOR PUBLIC COMMENT: ADVOCACY FOR RESCHEDULING MARIJUANA TO SCHEDULE V

YOUR NAME YOUR ADDRESS CITY, STATE, ZIP CODE EMAIL ADDRESS DATE

Drug Enforcement Administration Attn: DEA Federal Register Representative/DPW 8701 Morrissette Drive Springfield, Virginia 22152

RE: DOCKET NO. DEA202400590001

Dear Sir/Madam

I am writing to express my support for the rescheduling of marijuana to Schedule V under the Controlled Substances Act (CSA), as proposed in the DEA Rescheduling Draft Docket No. DEA-1362; A.G. Order No. 5931-2024. This letter outlines the key reasons for advocating this change based on the scientific, medical, and regulatory rationale provided in the draft.

LOWER POTENTIAL FOR ABUSE

Marijuana has been found to have a lower potential for abuse compared to substances in Schedule III. Its abuse potential is significantly less than that of drugs like heroin and cocaine, making Schedule V a more appropriate classification. Epidemiological data support this by showing fewer severe health outcomes related to marijuana use compared to higher-scheduled substances. CURRENTLY ACCEPTED MEDICAL USE Marijuana is recognized for its medical use in numerous states across the U.S., treating conditions such as chronic pain and nausea. The widespread acceptance and substantial clinical evidence of marijuana's therapeutic benefits justify its placement in Schedule V, which includes drugs with accepted medical uses and lower abuse potential. LIMITED DEPENDENCE LIABILITY Marijuana's potential for physical and psychological dependence is relatively low. The mild withdrawal symptoms observed further support this lower scheduling. Compared to Schedule IV substances, marijuana's dependence liability is less, making Schedule V a suitable classification. PUBLIC HEALTH AND SAFETY The safety profile of marijuana when used under medical supervision is well-established, with fewer severe adverse effects compared to higher-scheduled substances. Rescheduling marijuana to Schedule V would maintain necessary regulatory controls while allowing broader access for medical use, ensuring public health and safety are protected.

PAGE 17

Made with FlippingBook - professional solution for displaying marketing and sales documents online